Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
EXCH
CORESTEMCHEMON
★★★

CORESTEMCHEMON Receives Approval for Change in Product License for ALS Drug NeuroNata-ALZ, Paving Way for Domestic Sales

  05/26/2026, 05:23 PM
PERI
CORESTEMCHEMON
★

Corestemchemon Q1 Operating Loss Widens to KRW 6.0B; ALS Drug Production Halted

  05/15/2026, 03:54 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.